| Fibroblasts fuel immune escape in the tumor microenvironment EA De Jaeghere, HG Denys, O De Wever Trends in cancer 5 (11), 704-723, 2019 | 124 | 2019 |
| PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer S Tuyaerts, AMT Van Nuffel, E Naert, PA Van Dam, P Vuylsteke, ... BMC cancer 19, 1-10, 2019 | 47 | 2019 |
| Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo E De Jaeghere, E De Vlieghere, J Van Hoorick, S Van Vlierberghe, ... Biomaterials 158, 95-105, 2018 | 37 | 2018 |
| Tumour tissue transport after intraperitoneal anticancer drug delivery C Carlier, A Mathys, E De Jaeghere, M Steuperaert, O De Wever, ... International Journal of Hyperthermia 33 (5), 534-542, 2017 | 34 | 2017 |
| Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma … EA De Jaeghere, S Tuyaerts, AMT Van Nuffel, A Belmans, K Bogaerts, ... Cancer Immunology, Immunotherapy 72 (2), 475-491, 2023 | 24 | 2023 |
| Splenic hematopoietic and stromal cells in cancer progression J Steenbrugge, EA De Jaeghere, E Meyer, H Denys, O De Wever Cancer Research 81 (1), 27-34, 2021 | 23 | 2021 |
| Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates K Couvreur, E Naert, E De Jaeghere, P Tummers, A Makar, ... BMC cancer 18, 1-10, 2018 | 20 | 2018 |
| Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic: results from the longitudinal ONCOVID survey study EA De Jaeghere, H Kanervo, R Colman, W Schrauwen, P West, ... Cancers 14 (4), 1093, 2022 | 17 | 2022 |
| Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment L Lippens, M Van Bockstal, EA De Jaeghere, P Tummers, A Makar, ... International journal of cancer 147 (2), 554-564, 2020 | 17 | 2020 |
| Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer EA De Jaeghere, F Laloo, L Lippens, M Van Bockstal, K De Man, E Naert, ... Gynecologic oncology 159 (2), 335-343, 2020 | 15 | 2020 |
| How are OCD patients and family members dealing with the waxing and waning pattern of the COVID-19 pandemic? Results of a longitudinal observational study HLN Tandt, I Debruyckere, L Leyman, R Colman, EA De Jaeghere, ... Psychiatric Quarterly 92 (4), 1549-1563, 2021 | 13 | 2021 |
| Risk of thrombo-embolic events in ovarian cancer: does bevacizumab tilt the scale? A systematic review and meta-analysis M Saerens, EA De Jaeghere, H Kanervo, N Vandemaele, H Denys, ... Cancers 13 (18), 4603, 2021 | 11 | 2021 |
| Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a … A Van Damme, J Rombaut, A Makar, E De Jaeghere, E Naert, H Denys, ... World Journal of Surgical Oncology 21 (1), 84, 2023 | 5 | 2023 |
| Incorporating PARP-inhibitors into clinical routine: A tailored treatment strategy to tackle ovarian cancer E De Jaeghere, K Vandecasteele, K Claes, A Makar, P Tummers, ... Acta Clinica Belgica 72 (1), 6-11, 2017 | 5 | 2017 |
| The nocebo effect and tobacco control—First, do no harm? EA De Jaeghere, G Bouche, P Hoebeke, PM Holbrouck, HG Denys Medical Hypotheses 139, 109615, 2020 | 2 | 2020 |
| Treatment of ovarian cancer with intraperitoneal platinum: heating up the debate EA De Jaeghere, FB Gremonprez, PG Tummers, WC Willaert, WP Ceelen, ... Journal of Clinical Oncology 37 (33), 3169-+, 2019 | 2 | 2019 |
| 159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma EA De Jaeghere, S Tuyaerts, AMT Van Nuffel, L Lippens, A Hendrix, ... Annals of Oncology 32, S1449-S1450, 2021 | 1 | 2021 |
| Splenic metabolic activity as biomarker in cervical cancer EA De Jaeghere, F Laloo, L Lippens, K De Man, M Van Bockstal, ... Annals of Oncology 30, v47-v48, 2019 | 1 | 2019 |
| Identification of potentially actionable genetic variants in epithelial ovarian cancer: a retrospective cohort study C Fieuws, J Van der Meulen, K Proesmans, EA De Jaeghere, S Loontiens, ... NPJ precision oncology 8 (1), 71, 2024 | | 2024 |
| Performance of MRI for Detection of≥ pT1b Disease in Local Staging of Endometrial Cancer L Van Vynckt, P Tummers, H Denys, M Göker, S Hendrickx, E Naert, ... Cancers 16 (6), 1142, 2024 | | 2024 |
